Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M114Revenue (TTM) $M57.8Net Margin (%)-78.6Altman Z-Score-2.9
Enterprise Value $M69.6EPS (TTM) $-0.4Operating Margin %-22.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.5Pre-tax Margin (%)-78.6Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %-7.1Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow2.6y-y EBITDA Growth Rate %--ROA % (ttm)-16.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VVUS is held by these investors:



VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-16Sell305,090$1.1-0.91view
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-13Sell176,410$1.11-1.8view
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-08Sell563,527$1.062.83view
NORTH TIDE CAPITAL, LLC10% Owner 2017-02-03Sell78,633$1.12-2.68view
Varghese Santosh TChief Medical Officer 2017-01-28Sell429$1.11-1.8view
Varghese Santosh TChief Medical Officer 2016-12-31Sell13,790$1.12-2.68view
Varghese Santosh TChief Medical Officer, 10% Owner 2016-10-01Sell710$1.14-4.39view
Varghese Santosh TChief Medical Officer 2016-08-02Sell12,559$1.071.87view
Varghese Santosh TVP, Medical & Reg Affairs 2016-07-01Sell366$1.21-9.92view
Varghese Santosh TChief Medical Officer 2016-04-07Sell329$1.65-33.94view

Press Releases about VVUS :

Quarterly/Annual Reports about VVUS:

News about VVUS:

Articles On GuruFocus.com
Biotech Momentum Indicators: Achaogen (AKAO), Novartis (NVS), VIVUS (VVUS) Apr 01 2015 
5-year lows: PICO Holdings Inc, Black Box Corp, Vivus, and Electro Rent Corp. Mar 29 2015 
A Look at Pharma Company Dermira's Performance Mar 27 2015 
5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
Unique Investor Kyle Bass Unloads Five May 29 2013 
Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 

More From Other Websites
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 31 2017
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 18 2017
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 17 2017
VIVUS Licenses Rights to PAH Drugs from Selten Pharma Jan 11 2017
VIVUS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 10 2017
VIVUS INC Files SEC form 8-K, Other Events Jan 09 2017
VIVUS and Selten Pharma Announce Agreement for the Development and Commercialization Rights to... Jan 09 2017
VIVUS (VVUS): Will Qsymia & Stendra Sales Improve in 2017? Jan 03 2017
ETFs with exposure to VIVUS, Inc. : December 27, 2016 Dec 27 2016
Do Hedge Funds Love VIVUS, Inc. (VVUS)? Dec 14 2016
ETFs with exposure to VIVUS, Inc. : December 13, 2016 Dec 13 2016
Increased Earnings Estimates Seen for VIVUS (VVUS): Can It Move Higher? Dec 05 2016
VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session Nov 21 2016
ETFs with exposure to VIVUS, Inc. : November 18, 2016 Nov 18 2016
VIVUS INC Financials Nov 17 2016
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Submission of Matters... Nov 14 2016
VIVUS, Inc. :VVUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Nov 14 2016
VIVUS (VVUS) Reports Narrower-than-Expected Loss in Q3 Nov 11 2016
Edited Transcript of VVUS earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
VIVUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to... Nov 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)